Author: Dave Antrobus

The Range is set to unveil three new-format locations, transitioning from former Homebase stores.These openings mark the first phase of a larger plan following The Range’s acquisition of the Homebase brand.Stores in Glasgow, Bournemouth, and Birmingham will open as The Range Superstores on 17 January.The transformation promises job security, with plans to secure up to 1,600 positions throughout 2025.Homebase’s legacy is retained with dedicated sections like ‘Garden Centres by Homebase’ in the new stores.The Range is poised to launch its first three new-format superstores after acquiring the Homebase brand and several of its locations. This strategic move involves reopening former…

A new initiative aims to revolutionise in-orbit services through government support.Three space tech firms have been granted close to £1m for testing RPO.Astroscale UK, D-Orbit, and ClearSpace are key players in this endeavour.The initiative focuses on enhancing regulatory understanding and market growth.This project represents significant economic potential for the UK’s space sector.In a significant move for the UK space industry, a consortium of space technology firms has received government funding to advance in-orbit services. This initiative, backed by a grant of £690,000 from the Department for Science, Innovation and Technology (DSIT), is set to explore the potential of rendezvous and…

The US Food and Drug Administration has given its nod to Zepbound, a weight-loss drug now approved for obstructive sleep apnea. This is a remarkable evolution in treatment options for this widespread condition. Touted as a beacon of hope for millions, Zepbound ushers in a new approach by addressing both symptoms and root causes. It holds the promise of better health outcomes.Zepbound: A New Option for Obstructive Sleep ApneaThe introduction of Zepbound marks a significant development for those suffering from obstructive sleep apnea. This medication, linked to the class of GLP-1 receptor agonists, is pioneered by Eli Lilly. The approval…

The Original Factory Shop (TOFS), a well-known discount retail chain, is currently examining strategic directions with new advisors.Duke Street Capital, the private equity firm owning TOFS since 2007, has appointed Teneo for guidance in this exploration.Previously, TOFS collaborated with Deloitte to initiate a sale process, indicating ongoing strategic evaluations.Despite sale considerations, TOFS remains operational and anticipates strong Christmas sales.The pursuit of a strategic sale aligns with Duke Street’s historical efforts dating back to 2013.The Original Factory Shop (TOFS), a reputable discount retailer, has engaged new advisors to examine its strategic options, which could potentially lead to a sale. Duke Street…

Oxford Metrics has reported a downturn in sales and profits, highlighting the impact of extended buying cycles in its markets.The company’s revenue decreased over 6% to £41.5m for the fiscal year ending September.Pre-tax profits saw a significant decline, more than halving to £3.7m.While the UK and European markets reported growth, this was countered by declines in the US and Asia.Oxford Metrics remains in a strong financial position despite these challenges, supported by strategic acquisitions.Oxford Metrics, an Oxfordshire-based innovator in sensor and software technology, has disclosed a notable dip in its financial performance, attributing this downturn to extended purchasing timelines across…

N Brown Group’s £191m acquisition by Joshua Alliance receives FCA approval, clearing a key regulatory hurdle.The take-private offer will see Alliance’s family, holding a majority stake, buy remaining shares.Shareholders, including Frasers Group, have options to receive cash or Bidco shares.Initial agreement was reached in October 2024, now awaiting a court sanction in February.The move addresses N Brown’s shareholder structure inefficiencies and public listing costs.In a significant development, N Brown Group’s proposed £191 million acquisition by its non-executive director Joshua Alliance has obtained necessary approval from the Financial Conduct Authority (FCA), marking a critical step in the take-private process. This approval…

Boohoo’s board meeting with the Frasers Group excludes journalists, intensifying an ongoing leadership battle.The meeting focuses on Frasers Group’s push for Mike Ashley to join Boohoo’s board.Frasers Group has proposed restructuring experts to aid Boohoo’s financial struggles.Boohoo’s co-founder faces possible removal as part of Frasers’ plan.The outcome of the pivotal vote will be disclosed shortly.Boohoo Group, the prominent ecommerce firm, has decided to conduct its board meeting without media presence, highlighting a significant phase in its dispute with the Frasers Group. This meeting, closed to journalists, centres on a vote regarding Mike Ashley’s potential involvement in Boohoo’s board, as proposed…

Nike’s new CEO emphasises a return to sports-centric strategy in a bid for company resurgence.The CEO acknowledges the brand has shifted towards promotional activities, moving away from its sports roots.Recent financial results reveal a substantial dip, prompting strategic introspection and realignment.Competition from brands like Adidas has intensified, affecting Nike’s market position.Nike aims to leverage deep athlete insights to revitalise product innovation and brand storytelling.Nike’s newly appointed CEO, Elliott Hill, has articulated a clear vision to re-establish the brand’s sports-centric focus as a pivotal aspect of its strategic revival. Hill, who resumed his role at the company in October, articulated his…

The FDA’s latest action in redefining ‘healthy’ food labelling is both timely and transformative. Amid growing health concerns, these new guidelines are expected to influence consumer choices significantly. By aligning with scientific insights, the FDA aims to guide public dietary habits towards better health.These changes from the FDA propose a concrete shift in how ‘healthy’ foods are identified. Limiting unhealthy ingredients while promoting vital food groups, these guidelines attempt to align consumer health with available products. The clear objective is to aid consumers in making informed dietary decisions.Introduction to New FDA Labelling RequirementsThe US Food and Drug Administration (FDA) has…

The FDA has announced that the shortage of Eli Lilly’s major weight-loss and diabetes medications is resolved. This news marks a pivotal shift in patient access and could reshape healthcare delivery strategies.Eli Lilly’s drugs like Mounjaro and Zepbound, previously faced distribution challenges, impacting patients and the pharmaceutical market. With this resolution, the healthcare sector anticipates adjustments in both supply dynamics and commercial strategies.FDA’s Resolution on Drug ShortagesEli Lilly’s notable weight-loss and diabetes medicines, particularly Mounjaro and Zepbound, are no longer in shortage, as confirmed by the U.S. Food and Drug Administration (FDA). Such an announcement symbolizes a transformative moment in…